Clinical Trial Update: A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 HIV trial comparing two regimens (nelfinavir plus saquinavir plus delavirdine versus nelfinavir plus lamivudine/zidovudine) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Delavirdine (delavirdine)
• Lamivudine (lamivudine)
• Nelfinavir (nelfinavir)
• Saquinavir (saquinavir)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: WITHDRAWN